Magnetic-Bead Nucleic Acid Detection for Rapid Point-of-Care Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid detection methods, such as RT-PCR and LAMP, are complex, time-consuming, and require significant instrumentation and manual intervention, making them inefficient for rapid and minimally instrumented detection of analytes-of-interest in biological samples.

Innovation Solution

A device comprising magnetic beads with bound oligonucleotides and reporter molecules is used to detect nucleic acids, allowing for minimal sample preparation and rapid detection through a homogenous method that forms a complex with target nucleic acids, which is then separated and detected using a reporter molecule reaction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If RT-PCR or LAMP methods are used for nucleic acid detection, then detection sensitivity is improved, but device complexity and manual intervention requirements increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidinstrumentation complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines capture oligonucleotides, reporter oligonucleotides, and magnetic beads into a single integrated device structure. The capture oligonucleotide is attached to the magnetic bead, and the reporter oligonucleotide is hybridized to it, creating a unified detection system that eliminates the need for separate purification and amplification instruments required by RT-PCR and LAMP methods.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The magnetic bead serves as an intermediary carrier that holds the capture oligonucleotide and facilitates both capture and detection functions. This intermediary structure allows the device to perform multiple operations (capture, concentration, and detection) without requiring complex external instrumentation, thereby reducing device complexity while maintaining detection sensitivity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If RT-PCR or LAMP methods are used for nucleic acid detection, then detection accuracy is improved, but detection time increases

Engineering Contradiction:
Improvedetection accuracyVSAvoiddetection time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The capture oligonucleotide is pre-attached to the magnetic bead in a ready-to-use configuration. When the sample is introduced, the target nucleic acid is immediately captured without requiring preliminary purification steps. This preliminary preparation of the device structure eliminates time-consuming sample processing while maintaining detection accuracy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The device enables continuous detection action by having the reporter oligonucleotide already hybridized to the capture oligonucleotide on the magnetic bead. Upon target capture, the reporter can immediately hybridize to the target and generate a signal, eliminating the waiting periods and sequential steps required by RT-PCR and LAMP amplification cycles.

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If RT-PCR or LAMP methods are used for nucleic acid detection, then detection reliability is improved, but ease of operation deteriorates

Engineering Contradiction:
Improvedetection reliabilityVSAvoidmanual intervention requirement
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The magnetic bead device performs self-service by automatically capturing target nucleic acids and generating detection signals without requiring manual intervention for purification or amplification. The capture oligonucleotide on the magnetic bead self-assembles with the target, and the reporter oligonucleotide self-hybridizes to produce the signal, making the operation simple and reliable.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The single magnetic bead device structure performs multiple functions (capture, concentration, and detection) that traditionally required separate instruments and manual operations in RT-PCR and LAMP systems. This multi-functional design improves ease of operation while maintaining detection reliability through integrated functionality.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables fast, efficient, and sensitive detection of nucleic acids with minimal instrumentation, suitable for point-of-care applications, reducing turnaround time and eliminating the need for complex purification or amplification steps.

Implementation Method 1

a magnetic bead, one or more oligonucleotides bound to the magnetic bead

Methodology Applied
Scientific EffectMagnetic properties: Magnetism

Implementation Method 2

one or more oligonucleotides are preselected in length, and chemical composition... one or more oligonucleotides are double stranded and include a loop structure... one of the first or second single stranded nucleic acid segments is characterized as an analyte specific binding segment

Methodology Applied
Scientific EffectNucleic acid hybridization: Chemical Bonding

Data Source

PatentUS20250215483A1Device, apparatus and method for detecting nucleic acids
Publication Date: 2025.07.03 SIEMENS HEALTHCARE DIAGNOSTICS INC
  • US20250215483A1 patent drawing
  • US20250215483A1 patent drawing
  • US20250215483A1 patent drawing

AI summary

The present disclosure refers to a homogeneous method, apparatus and device for detection of target nucleic acids in a sample. In one aspect, the device includes a magnetic bead. Further, the device includes one or more oligonucleotides bound to the magnetic bead. Additionally, the device includes at least one reporter molecule linked to the one or more oligonucleotides.